These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 498948)

  • 1. Naftidrofuryl (Praxilene) in peripheral vascular disease.
    Drug Ther Bull; 1979 Oct; 17(21):83-4. PubMed ID: 498948
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of naftidrofuryl (praxilene) on the peripheral cerebral circulation. Dynamometric and dynamographic control].
    Barut C; Roch MT
    Bull Soc Ophtalmol Fr; 1974; 74(7-8):771-8. PubMed ID: 4469472
    [No Abstract]   [Full Text] [Related]  

  • 3. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E; Bahnini A; Mouren X; Gamand S
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravenous naftidrofuryl on transcutaneous oxygen pressure in severe peripheral vascular disease.
    Taggart I; Wishart GC; Cuschieri RJ; MacBain GC
    Angiology; 1989 Oct; 40(10):895-8. PubMed ID: 2802260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of naftidrofuryl on the ischemia model in healthy probands].
    Rudofsky G
    Vasa; 1988; 17(3):199-207. PubMed ID: 3051762
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of naftidrofuryl (Praxilene) on intermittent claudication.
    Waters KJ; Craxford AD; Chamberlain J
    Br J Surg; 1980 May; 67(5):349-51. PubMed ID: 6992910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of naftidrofuryl (Praxilene) in the treatment of intermittent claudication.
    Clyne CA; Galland RB; Fox MJ; Gustave R; Jantet GH; Jamieson CW
    Br J Surg; 1980 May; 67(5):347-8. PubMed ID: 6992909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Naftidrofuryl in the therapy of chronic arterial occlusive disease in the intermittent claudication stage].
    Valentin A; Karnik R; Stöllberger C; Slany J
    Vasa Suppl; 1987; 20():361-4. PubMed ID: 3321493
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical effectiveness of naftidrofuryl in intermittent claudication].
    Kriessmann A; Neiss A
    Vasa Suppl; 1988; 24():27-32. PubMed ID: 3062823
    [No Abstract]   [Full Text] [Related]  

  • 10. Naftidrofuryl for ischaemic rest pain: a controlled trial.
    Greenhalgh RM
    Br J Surg; 1981 Apr; 68(4):265-6. PubMed ID: 7013892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of constriction of cerebral arterioles in vivo by naftidrofuryl. Action against serotonin and dinoprost.
    Rosenblum WI
    Arzneimittelforschung; 1987 May; 37(5):495-7. PubMed ID: 3476118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naftidrofuryl: a review of its use in the treatment of intermittent claudication.
    Goldsmith DR; Wellington K
    Drugs Aging; 2005; 22(11):967-77. PubMed ID: 16323973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of naftidrofuryl oxalate (Praxilene) on blood flow in the experimental saphenous flap model.
    Awwad AM; White RJ; Webster MH; Vance JP
    Br J Plast Surg; 1983 Oct; 36(4):460-2. PubMed ID: 6626826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial prostacyclin compared to Praxilene in the management of severe lower limb ischaemia: a double blind trial.
    Negus D; Irving JD; Friedgood A
    J Cardiovasc Surg (Torino); 1987; 28(2):196-9. PubMed ID: 2435738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of naftidrofuryl oxalate (praxilene) on peripheral circulation measured by calorimetry.
    Tan OT; Gaylarde PM; Sarkany I
    Australas J Dermatol; 1978 Aug; 19(2):51-3. PubMed ID: 728015
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of naftidrofuryl ('Praxilene') on hepatic microsomal enzymes.
    Majumdar SK; Shaw GK; Thomson AD
    Pharmatherapeutica; 1980; 2(5):305-8. PubMed ID: 6107932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular effects of naftidrofuryl in a randomized placebo-controlled double-blind study.
    Jung F; Wolf S; Kiesewetter H
    Arzneimittelforschung; 1989 Oct; 39(10):1277-80. PubMed ID: 2610721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Capillary microscopic effect of naftidrofuryl in peripheral arterial occlusive disease].
    Heidrich H; Ranft J
    Vasa Suppl; 1988; 24():17-20. PubMed ID: 3212599
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with solcoseryl in treatment of stage II peripheral arterial occlusive disease--assessment of clinical effectiveness].
    Horsch S; Claeys L
    Vasa Suppl; 1992; 35():151-2. PubMed ID: 1481024
    [No Abstract]   [Full Text] [Related]  

  • 20. [Assessment of the clinical effectiveness of actihaemyl in Fontaine stage IIb intermittent claudication].
    Horsch S; Claeys L; Diehm C; Rieger H; Cachovan M; Baitsch C
    Vasa Suppl; 1992; 37():64-5. PubMed ID: 1481105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.